Prudential Financial Inc. Has $5.88 Million Position in Solventum Co. (NYSE:SOLV)

Prudential Financial Inc. decreased its stake in shares of Solventum Co. (NYSE:SOLV - Free Report) by 6.0% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 88,940 shares of the company's stock after selling 5,638 shares during the period. Prudential Financial Inc. owned 0.05% of Solventum worth $5,875,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in SOLV. Modus Advisors LLC bought a new position in shares of Solventum in the fourth quarter worth about $25,000. Stonebridge Financial Group LLC acquired a new stake in shares of Solventum in the fourth quarter worth $26,000. Crews Bank & Trust bought a new position in Solventum during the fourth quarter worth $32,000. True Wealth Design LLC boosted its holdings in Solventum by 23,550.0% in the 3rd quarter. True Wealth Design LLC now owns 473 shares of the company's stock valued at $33,000 after purchasing an additional 471 shares during the period. Finally, Synergy Asset Management LLC acquired a new stake in Solventum in the 4th quarter worth $35,000.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on SOLV shares. Morgan Stanley increased their target price on shares of Solventum from $73.00 to $80.00 and gave the company an "equal weight" rating in a research note on Wednesday, March 5th. Mizuho raised their price objective on Solventum from $70.00 to $82.00 and gave the stock a "neutral" rating in a research report on Monday, March 3rd. The Goldman Sachs Group boosted their price objective on Solventum from $63.00 to $71.00 and gave the company a "sell" rating in a research report on Monday, March 3rd. Bank of America raised their target price on Solventum from $80.00 to $85.00 and gave the stock a "neutral" rating in a research report on Wednesday, February 26th. Finally, Piper Sandler boosted their price target on shares of Solventum from $75.00 to $84.00 and gave the company a "neutral" rating in a report on Friday, February 28th. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating and one has assigned a buy rating to the company. Based on data from MarketBeat, Solventum has an average rating of "Hold" and a consensus target price of $79.86.

Solventum Price Performance

SOLV stock traded down $3.97 during midday trading on Friday, reaching $66.22. 1,873,221 shares of the company's stock traded hands, compared to its average volume of 1,370,900. The company has a quick ratio of 0.83, a current ratio of 1.15 and a debt-to-equity ratio of 2.45. The company has a market cap of $11.45 billion and a price-to-earnings ratio of 24.08. The company has a 50-day simple moving average of $75.42 and a two-hundred day simple moving average of $71.95. Solventum Co. has a 1-year low of $47.16 and a 1-year high of $85.92.

Solventum Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.